NO147306C - Analogifremgangsmaate ved fremstilling av nye, farmakologisk aktive piperazinderivater - Google Patents
Analogifremgangsmaate ved fremstilling av nye, farmakologisk aktive piperazinderivaterInfo
- Publication number
- NO147306C NO147306C NO774294A NO774294A NO147306C NO 147306 C NO147306 C NO 147306C NO 774294 A NO774294 A NO 774294A NO 774294 A NO774294 A NO 774294A NO 147306 C NO147306 C NO 147306C
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- pharmacologically active
- piperazine derivatives
- analogy procedure
- new pharmacologically
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/78—Ring systems having three or more relevant rings
- C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans
- C07D311/82—Xanthenes
- C07D311/84—Xanthenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 9
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Anesthesiology (AREA)
- Diabetes (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Furan Compounds (AREA)
- Pyrane Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU76RI605A HU174215B (hu) | 1976-12-15 | 1976-12-15 | Sposob poluchenija novykh proizvodnykh piperazina i kislotnykh additivnykh i chetvjortichnykh solej |
Publications (3)
Publication Number | Publication Date |
---|---|
NO774294L NO774294L (no) | 1978-06-16 |
NO147306B NO147306B (no) | 1982-12-06 |
NO147306C true NO147306C (no) | 1983-03-16 |
Family
ID=11001009
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO774294A NO147306C (no) | 1976-12-15 | 1977-12-14 | Analogifremgangsmaate ved fremstilling av nye, farmakologisk aktive piperazinderivater |
Country Status (21)
Country | Link |
---|---|
US (2) | US4140790A (no) |
JP (2) | JPS6026114B2 (no) |
AT (1) | AT359507B (no) |
BE (1) | BE861849A (no) |
CA (1) | CA1080219A (no) |
CH (1) | CH632750A5 (no) |
DE (1) | DE2755707A1 (no) |
ES (1) | ES465061A1 (no) |
FI (1) | FI65427C (no) |
FR (1) | FR2374322A1 (no) |
GB (1) | GB1580227A (no) |
HU (1) | HU174215B (no) |
IL (1) | IL53552A (no) |
IN (1) | IN146474B (no) |
NL (1) | NL7713827A (no) |
NO (1) | NO147306C (no) |
PT (1) | PT67403B (no) |
SE (1) | SE430159B (no) |
SU (1) | SU694071A3 (no) |
YU (1) | YU293677A (no) |
ZA (1) | ZA777398B (no) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU174215B (hu) * | 1976-12-15 | 1979-11-28 | Richter Gedeon Vegyeszet | Sposob poluchenija novykh proizvodnykh piperazina i kislotnykh additivnykh i chetvjortichnykh solej |
US4703120A (en) * | 1986-04-28 | 1987-10-27 | Ortho Pharmaceutical Corporation | Furo(3,4-d)pyrimidine-2,4-dione derivatives and intermediates thereof |
CN1060168C (zh) * | 1994-05-06 | 2001-01-03 | 中国人民解放军军事医学科学院毒物药物研究所 | 新的呫吨衍生物,其制备方法及含它们的药物组合物 |
PL371486A1 (en) | 2002-02-01 | 2005-06-13 | Astrazeneca Ab | Quinazoline compounds |
CA2521330A1 (en) * | 2003-04-08 | 2004-10-21 | Neuromed Technologies, Inc. | Calcium channel inhibitors comprising benzhydril spaced from piperazine |
US20080207738A1 (en) * | 2007-02-28 | 2008-08-28 | Cancure Laboratories, Llc | Drug combinations to treat drug resistant tumors |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3481930A (en) * | 1966-11-21 | 1969-12-02 | American Home Prod | Xanthene and thioxanthene-9 ureas and propionamides |
US3502662A (en) * | 1968-03-18 | 1970-03-24 | American Home Prod | N-(9-xanthenyl or thioxanthenyl)-3-amino or iodo-propionamides and 4-(9-xanthenyl or thioxanthenyl)-thiosemicarbazones |
FR2201084B1 (no) * | 1972-09-29 | 1975-10-31 | Bouchara Emile | |
US3953449A (en) * | 1973-05-09 | 1976-04-27 | Synthelabo | 2-(4-M-CF3 or -SCF3 phenylpiperazino)-ethyl benzoates |
HU174215B (hu) * | 1976-12-15 | 1979-11-28 | Richter Gedeon Vegyeszet | Sposob poluchenija novykh proizvodnykh piperazina i kislotnykh additivnykh i chetvjortichnykh solej |
-
1976
- 1976-12-15 HU HU76RI605A patent/HU174215B/hu unknown
-
1977
- 1977-11-25 JP JP52140843A patent/JPS6026114B2/ja not_active Expired
- 1977-12-02 CH CH1475877A patent/CH632750A5/de not_active IP Right Cessation
- 1977-12-05 AT AT867677A patent/AT359507B/de not_active IP Right Cessation
- 1977-12-06 IL IL53552A patent/IL53552A/xx unknown
- 1977-12-07 SE SE7713906A patent/SE430159B/xx unknown
- 1977-12-09 FR FR7737196A patent/FR2374322A1/fr active Granted
- 1977-12-12 US US05/859,928 patent/US4140790A/en not_active Expired - Lifetime
- 1977-12-12 IN IN1717/CAL/77A patent/IN146474B/en unknown
- 1977-12-12 ZA ZA00777398A patent/ZA777398B/xx unknown
- 1977-12-12 FI FI773743A patent/FI65427C/fi not_active IP Right Cessation
- 1977-12-12 YU YU02936/77A patent/YU293677A/xx unknown
- 1977-12-13 SU SU772555706A patent/SU694071A3/ru active
- 1977-12-14 CA CA293,096A patent/CA1080219A/en not_active Expired
- 1977-12-14 GB GB52038/77A patent/GB1580227A/en not_active Expired
- 1977-12-14 JP JP14945477A patent/JPS5377073A/ja active Pending
- 1977-12-14 PT PT67403A patent/PT67403B/pt unknown
- 1977-12-14 NO NO774294A patent/NO147306C/no unknown
- 1977-12-14 NL NL7713827A patent/NL7713827A/xx not_active Application Discontinuation
- 1977-12-14 BE BE183452A patent/BE861849A/xx not_active IP Right Cessation
- 1977-12-14 DE DE19772755707 patent/DE2755707A1/de not_active Ceased
- 1977-12-14 ES ES465061A patent/ES465061A1/es not_active Expired
-
1978
- 1978-12-28 US US05/974,082 patent/US4250310A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
DE2755707A1 (de) | 1978-06-29 |
NO774294L (no) | 1978-06-16 |
BE861849A (fr) | 1978-03-31 |
IL53552A (en) | 1981-07-31 |
SE430159B (sv) | 1983-10-24 |
JPS5377073A (en) | 1978-07-08 |
PT67403A (en) | 1978-01-01 |
NL7713827A (nl) | 1978-06-19 |
FR2374322A1 (fr) | 1978-07-13 |
YU293677A (en) | 1982-08-31 |
GB1580227A (en) | 1980-11-26 |
PT67403B (en) | 1979-05-21 |
AT359507B (de) | 1980-11-10 |
SE7713906L (sv) | 1978-06-16 |
IN146474B (no) | 1979-06-16 |
FI773743A (fi) | 1978-06-16 |
ATA867677A (de) | 1980-04-15 |
FI65427B (fi) | 1984-01-31 |
ZA777398B (en) | 1978-10-25 |
US4140790A (en) | 1979-02-20 |
IL53552A0 (en) | 1978-03-10 |
CH632750A5 (de) | 1982-10-29 |
ES465061A1 (es) | 1979-01-01 |
JPS6026114B2 (ja) | 1985-06-21 |
US4250310A (en) | 1981-02-10 |
HU174215B (hu) | 1979-11-28 |
NO147306B (no) | 1982-12-06 |
JPS5377080A (en) | 1978-07-08 |
FI65427C (fi) | 1984-05-10 |
SU694071A3 (ru) | 1979-10-25 |
FR2374322B1 (no) | 1981-11-27 |
CA1080219A (en) | 1980-06-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO151085C (no) | Analogifremgangsmaate ved fremstilling av nye, terapeutisk aktive peptidylargininaldehydderivater | |
NO153136C (no) | Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive naftyridinderivater. | |
NO153177C (no) | Analogifremgangsmaate for fremstilling av farmakologisk aktive tetrazolylalkoksy-karbostyrilderivater. | |
NO145199C (no) | Analogifremgangsmaate for fremstilling av farmakologisk aktive nortropinestere. | |
NO154919C (no) | Analogifremgangsmaate ved fremstilling av nye kinazolinderivater. | |
NO800626L (no) | Analogifremgangsmaate for fremstilling av farmakologisk aktive polyolderivater | |
NO148813C (no) | Analogifremgangsmaate for fremstilling av farmakologisk aktive karbostyrilderivater | |
NO160211C (no) | Analogifremgangsmaate til fremstilling av nye terapeutisk virksomme cefemderivater. | |
NO147148C (no) | Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive fenyletanolaminderivater | |
NO149733C (no) | Analogifremgangsmaate ved fremstilling av nye, terapeutisk aktive acylderivater av carnitin | |
NO150884C (no) | Analogifremgangsmaate for fremstilling av nye, terapeutisk aktive imidazotiazolderivater | |
NO145792C (no) | Analogifremgangsmaate for fremstilling av farmakologisk aktive pyrimidon-derivater | |
NO143846C (no) | Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive 1,4-dihydropyridinderivater | |
NO154426C (no) | Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive trans-3-(4-okso-4h-kinazolin-3-yl)-2-propensyrederivater. | |
NO148416C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazolidin-, morfolin- og tiazan-derivater | |
NO148642C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive, nye prostacyclinderivater | |
NO145842C (no) | Analogifremgangsmaate for fremstilling av farmakologisk aktive indolizinderivater | |
NO152654C (no) | Analogifremgangsmaate ved fremstilling av nye, terapeutisk aktive derivater av 7-acylamido-3-cephem-4-karboksylsyre | |
NO145791C (no) | Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive imidazolderivater | |
NO153725C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive nye 4-(nafthylmethyl)-piperidin-derivater. | |
NO148926C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive, nye merkaptoimidazolderivater | |
NO142625C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive, nye piperazinderivater | |
NO150882C (no) | Analogifremgangsmaate ved fremstilling av nye 1,4-benzoksazin-derivater | |
NO154920C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive, nye pyridothienotriaziner. | |
NO149388C (no) | Analogi-fremgangsmaate for fremstilling av farmakologisk aktive karbostyril-derivater |